The CDK1/TFCP2L1/ID2 cascade offers a novel combination therapy strategy in a preclinical model of bladder cancer.
Heo J, Lee J, Nam YJ, Kim Y, Yun H, Lee S, Ju H, Ryu CM, Jeong SM, Lee J, Lim J, Cho YM, Jeong EM, Hong B, Son J, Shin DM.
Heo J, et al. Among authors: son j.
Exp Mol Med. 2022 Jun;54(6):801-811. doi: 10.1038/s12276-022-00786-0. Epub 2022 Jun 21.
Exp Mol Med. 2022.
PMID: 35729325
Free PMC article.